GetTopicDetailResponse(id=38a38e26df, topicName=HER2單抗, introduction=HER2單抗, content=null, image=null, comments=2, allHits=1092, url=https://h5.medsci.cn/topic?id=8726, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=95938, tagList=[TagDto(tagId=95938, tagName=HER2單抗)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1653772, encodeId=e1051653e7271, content=<a href='/topic/show?id=38a38e26df' target=_blank style='color:#2F92EE;'>#HER2單抗#</a>, objectTitle=MacroGenics宣布HER2單抗Margetuximab在轉(zhuǎn)移性乳腺癌患者中的III期臨床SOPHIA的第二次總體中期生存數(shù)據(jù), objectType=article, longId=181811, objectId=3a1a18181105, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a1a18181105, replyNumber=0, likeNumber=70, createdTime=2020-06-17, rootId=0, userName=119337465, userId=2ac724357504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a1a18181105, moduleTitle=MacroGenics宣布HER2單抗Margetuximab在轉(zhuǎn)移性乳腺癌患者中的III期臨床SOPHIA的第二次總體中期生存數(shù)據(jù), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=3a1a18181105)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653773, encodeId=34d81653e7333, content=<a href='/topic/show?id=38a38e26df' target=_blank style='color:#2F92EE;'>#HER2單抗#</a>, objectTitle=Fc優(yōu)化的HER2單抗Margetuximab治療胃癌，獲得FDA授予孤兒藥稱號, objectType=article, longId=195469, objectId=9caa195469c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9caa195469c7, replyNumber=0, likeNumber=111, createdTime=2021-04-12, rootId=0, userName=119337465, userId=2ac724357504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9caa195469c7, moduleTitle=Fc優(yōu)化的HER2單抗Margetuximab治療胃癌，獲得FDA授予孤兒藥稱號, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9caa195469c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
